Authors: KRAWCZYK CM VERSTOVSEK S UJHAZY P MACCUBBIN D EHRKE MJ

Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE (VOL 40, PG 347, 1995)/, Cancer immunology and immunotherapy, 45(1), 1997, pp. 60-60

Authors: KRAWCZYK CM VERSTOVSEK S UJHAZY P MACCUBBIN D EHRKE MJ

Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE/, Cancer immunology and immunotherapy, 40(6), 1995, pp. 347-357

Authors: UJHAZY P MACCUBBIN D EPPOLITO C MIHICH E EHRKE MJ

Citation: P. Ujhazy et al., TNF-ALPHA POTENTIATION OF THE LYMPHOKINE-ACTIVATED KILLER RESPONSE OFMURINE THYMUS-CELLS, Lymphokine and cytokine research, 13(2), 1994, pp. 99-106

Authors: ZALESKIS G HO RLX DIEGELMAN P MACCUBBIN D UJHAZY P MIHICH E EHRKE MJ

Citation: G. Zaleskis et al., INTRACELLULAR DOXORUBICIN KINETICS IN LYMPHOMA-CELLS AND LYMPHOCYTES INFILTRATING THE TUMOR AREA IN-VIVO - A FLOW CYTOMETRIC STUDY, Oncology research, 6(4-5), 1994, pp. 183-194

Authors: HO RLX MACCUBBIN D ZALESKIS G KRAWCZYK C WING K MIHICH E EHRKE MJ

Citation: Rlx. Ho et al., DEVELOPMENT OF A SAFE AND EFFECTIVE ADRIAMYCIN PLUS INTERLEUKIN-2 THERAPY AGAINST BOTH ADRIAMYCIN-SENSITIVE AND ADRIAMYCIN-RESISTANT LYMPHOMAS, Oncology research, 5(9), 1993, pp. 373-381